Kenneth J Hoffer, M.D. 411 Lincoln Blvd Santa Monica, CA 90402

August 5, 2015

To: The Nominating Committee of the IIIC

I would like nominate Prof Johnny Moore MD of Belfast, Ireland for membership in the International Intraocular Implant Club. Johnny is a prominent ophthalmic surgeon, researcher and educator in Northern Ireland.

He is active on the staff of the University of Ulster in Belfast and has been involved in research and innovation in cataract and refractive surgery.

He also has a most enjoyable personality that will be enjoyed by our members.

I highly recommend his nomination for membership to the IIIC.

With best regards,

Kenneth J Hoffer, MD FACS

Member IIIC

His contact information:

Johnny Moore MD, PhD, FRCOpth johnnymoorebal@googlemail.com

Cathedral Eye Clinic University Of Ulster York Street Belfast, Northern Ireland United Kingdom BT15 1ED +353-28 9032 2020

RE: Nomination for IIIC membership of Professor Johnny Moore FRCOphth, PhD, MD

Dear Nominating Committee, I would like to propose Prof. Johnny Moore as a new member of the Inter-national Intra-ocular Implant Club (IIIC). He is currently Medical Director at the Cathedral Eye Clinic, Belfast, Northern Ireland and a Consultant Ophthalmic Surgeon at Mater Hospital, Belfast Trust. I got to know Johnny in our search to find a new European Associate Editor for the Journal of Cataract and Refractive Surgery. Johnny was one of the candidates and greatly impressed me with his drive and vision. He specialises in ocular surface reconstruction, laser refractive surgery, cataract and other intraocular eye surgery and, as his CV details, he has completed in the region 13,000 procedures making him a highly experien-ced clincian. In addition to performing surgery, Johnny is involved in tea-ching, training and research. He helps run an online PGDip/MSc Cataract and Refractive Surgery course through the University of Ulster and collabo-rates with a number of researchers at the University. He has over 70 pu-blished journal articles and regularly presents at international conferences. On a personal note, Johnny appears to be straightforward and hardworking with a real interest in IOL research. I believe that Johnny meets the criteria for membership and recommend him to the membership and Executive Committee. Yours sincerely,

Thomas Kohnen, MD, PhD, FEBO Chair & Professor of Ophthalmology Goethe University, Frankfurt

Universitätsklinikum . Theodor-Stern-Kai 7 . 60590 Frankfurt Michael Knorz Nominating Committee International Intra-Ocular Implant Club

Klinik für Augenheilkunde Direktor: Prof. Dr. T. Kohnen Editorial Assistant Prof. Dr. T. Kohnen Tel. 069/6301-3945 Fax: 069/6301-3893 Bearbeiterin: A Rowan McEwan

Datum: 18.01.2016

Direktionssekretariat Tel.: 069/6301-3945 Fax: 069/6301-3893 Privatambulanz Tel.: 069/6301-5187/-5056 Fax: 069/6301-6586 Notfälle Tel.: 069/6301-5110 Fax: 069/6301-5233 Hochschulambulanz Tel.: 069/6301-5098 Fax: 069/6301-5233 Stationäre Aufnahme Tel.: 069/6301-5397 Fax: 069/6301-5233 Refraktive Chirurgie Tel.: 069/6301-5618 Fax: 069/6301-5805 Vorderer Augenabschnitt Katarakt-, Hornhaut-, Glaukomsprechstunde Tel.: 069/6301-83429 Fax: 069/6301-5805 Netzhaut- und Glaskörperchirurgie Tel.: 069/6301-5649 Fax: 069/6301-5621 Kinderaugenheilkunde und Schielbehandlung Lid- und Tränenwegschirurgie Tel.: 069/6301-5721 Fax: 069/6301-7795 Studienzentrale Tel.: 069/6301-83493 Fax: 069/6301-3893 www.uni-augenklinik-frankfurt.de

ProfessorJohnnyMooreConsultantOphthalmologist

CathedralEyeClinic 89-91AcademyStreet Belfast BT12LS

6thMay2016

Prof.MichaelC.KnorzExecutiveDirectorInternationalIntraocularImplantClub(IIIC)FreeVisLASIKZentrumTheodorKutzerUfer1-368167MannheimGermany

DearProfessorKnorz

Further tomynomination formembership to the International Intra-Ocular Implant Clubby Prof.KohnenandDr.HofferIamwritingtoinformyouthatIamverywillingtobecomeamemberofIIIC.

On reviewing the copy of the membership process I feel I meet the five essential criteria forcandidacy.

I currently carryout on average 15-20 IOL implants each week both for cataracts, clear lensextractionandphakicIOLsbetweenNHSandprivatepractice.Isetupandco-runtheIOLportionoftheonlinecataractandrefractivecoursefortheUniversityofUlster,whichhasbeenrunningnowforover8 years andhasbeen fully revamped this year aspartof its collaborationwith theRoyalCollege of Ophthalmology. I currently publish in the field of implantology and have recentlydeveloped an iphone app to assist junior surgeons with implantology surgery. I attend andcontribute regularly to various national and international meetings such as UKISCRS, BSRS andESCRS.

IwouldalsoliketoconfirmthatIshallbeavailabletofellowIIICmembersforconsultationandtheexchange of ideas and information; shall regularly attendmeetings of the IIIC and participate, asappropriate, in clinical, laboratory, or combined research concerning intraocular implantation andshalldisseminatetheexperienceandknowledgeobtained.

KindRegards

JohnnyMoore

BackgroundIcompletedamedicaldegreefromQueensUniversityBelfast(QUB),trainedinophthalmologyintheDepartment ofOphthalmology, Belfast then carried out an anterior segment clinical fellowship inAdelaideSouthAustraliaandthenachievedaPhDinOphthalmologyfromQUBwithayearofthisasa research fellowship position in HarvardMedical School, Boston under the tutelage of ProfessorTonyAdamisandProfessorDimitriAzar.Since2007IhavebeeninaconsultantophthalmologypositionintheMaterHospital,BelfastTrust,whereIdevelopedandrantheanteriorsegmentservice,introducinganddevelopingnewtechnicalprocedures such as DSAEK, DMEK procedures, INTACs, Crosslinking, topography guided lasertreatments to manage irregular corneal astigmatism and opacities, novel pterygium operativetechniques,mechanismstomanagemoreaccuratelyIOLpowerpredictionsaftercornealrefractivetreatments andmore recently the use of fingertip blood tomanage chronic non healing cornealulcers.IamalsoMedicalDirectorofCathedralEyeClinicwhichoffersspecialistexpertiseinlaser,refractivesurgery,cataractsurgery,anteriorsegmentsurgery,multifocalIOLs,medicalandsurgicalretinaandoculoplasticsurgery.TheClinicalsohasastrongcommitmenttoevidencebasedresearchtoimprovepatient care and Cathedral Eye Research Foundation has sponsored numerous research activitiesovertheyearsincludingsponsorshipofDrVictoriaMcGilligan’ssecondmenttocolleaguesinHarvardMedicalSchoolBoston.CathedralEyeClinichasbeenworkingwiththeasymmetricmultifocalIOLsnowforoversevenyearsandProfessorMoorewasthefirstpersonintheUKtoimplantoneoftheseIOLs.Sincethattimewehave consistently evaluated the response of patients to these types of IOLs and continued toresearchtodeterminethe individualpreoperativeprognostic factorswhichcanenableustoavoidinputting these IOLs into someone whomight get a suboptimal result and also the implantationtechniques required to optimise the outcomes in any individual where the IOL is implanted. Thisresearchhasresultedinvariouspublicationswithmorerecentlysubmittedandunderreview.Ihaverecentlydevelopedasurgicalapptohelpguidetraineesincataractsurgery-thisisabouttobereleasedthroughappleitunesforuseinanyappleproduct.Iamalsoactively involvedinresearchwithProfessorTaraMooreattheUniversityofUlster inthedevelopment of novel genetic tools designed to manage various corneal and ocular surfacepathologies. IworkcloselywithDrAndrewNesbitandDrSarahAtkinson in identifyingnovelgenecauses for various ocular pathologies presenting at this clinics. I am co applicant onmany visionscience research grants, am chief investigator on a number of projects, supervise numerous PhDstudents,publishinvarioushighimpactjournalsandpresentatmanyinternationalmeetings.RecentlyIhavebeeninvolvedinthecreationofanovelpatienttooltoassistinthepropermassageof the eyelids to treat obstructive meibomian gland dysfunction- this is called ‘eyepeace’ themarketingprocessforthisCEmarkeddevicehasjustnowbeencommenced.I have also recently developed a dry eye care app called Eye Care. The Dry Eye-3 (DE-3)Questionnaire allows patients to monitor and assess the ocular surface symptomatology and

ConsultantOphthalmologistVisitingProfessor,UlsterUniversityMB.,BCh.,BAO.,FRCOphth.,Ph.DCathedraleyeClinic,89-91AcademyStreet,Belfast,BT12LST:+44(0)7894552387E:jmooreccathedral@gmail.com

JohnnyMoore

treatment. Three short questions that alternate every week are designed to rapidly assess theseverity and treatment outcomeof your eyes.Using this app as a part of their eye carewill helpenhance their outcome. This app will also keep patients informed about the latest research,treatmentandeyespecialists.In2013IgainedthepositionofAnteriorSegmentLeadwithintheBelfasttrustafteracompetitiveapplicationprocess,andmovedmyNHSpracticetotheRoyalVictoriaHospitalSite.Iamanactivereviewerformanydifferentinternationalophthalmicjournals.I amalso a joint course-director andmodule co-ordinator for the jointly badgedUlsterUniversityandTheRoyalCollegeofOphthalmologist(RCOphth)PGDiplomainCataractandRefractivesurgical.This programme has been designed in collaboration with The Royal College of Ophthalmologists(RCOphth)standards,curriculumandexaminationcommitteesandisthepreparatorycoursefortheRCOphthCertificateinLaserRefractiveSurgery.ItistheonlyendorsedRCOphthrefractivesurgeryprogrammecompletedfullyonlineintheUK.Ihave recentlypublishedonebookon themathematics relating toastigmatism in thehumaneye‘Biometrics of Astigmatism in theHuman Eye’ by E.A.Goodall, J.Moore 2014, alongwith variouspublicationsofuseofasymmetricmultifocalIOLs.CurrentCareerProfileAnteriorSegmentLead,RoyalGroupofHospitals,Belfast 2013-presMedicalDirector,CathedralEyeClinic,Belfast 2008-presConsultantOphthalmologist,RoyalGroupofHospitals,Belfast 2007-presVisitingProfessor,CentreforMolecularBiosciences,UlsterUniversity 2004-presRecognisedTeacher,UlsterUniversity 2004-presRecognisedPhDSupervisor,UlsterUniversity 2004-presRecognisedETutor,UlsterUniversity 2004-presEducationandEmploymentLocumConsultantRoyalGroupofHospitals&LaganValleyHospital 2003-2006Clinicalanteriorsegmentfellow,Birmingham&MidlandsEyeCentre& DepartmentofOphthalmology,BedfordHospital,Bedford 2002-2003SpecialistRegistrarOphthalmologyDepartment,RVH,Belfast 2001-2002ConsultantOphthalmologist,RoyalGroupofHospitals,Belfast 2001-2002ClinicalanteriorsegmentfellowFlindersMedicalSchoolAdelaide,Australia 2000ResearchFellow,OphthalmologyDepartment,RVH,Belfast 1999-2001Ph.D.Student,Queen’sUniversityofBelfast,UKPhD 2002Certificateofcompletionofspecialisttraining(CCST),RoyalCollegeofOphthalmology 2002FRCOphth.PartIIIRoyalCollegeofOphthalmology,UK 1996FRCOphth.PartII(OpticsandRefractionModule)RoyalCollegeofOphthalmology 1994FRCOphth.PartIRoyalCollegeofOphthalmology,UK 1993MB.,BCh.,BAO.Queen’sUniversityofBelfast 1991CommissionsofTrustExpertReviewerfor15journalsincluding4top10journalsinOphthalmology(IOVS,BJO)MemberoftheBritishMedicalAssociation

MemberofEuropeanVisionandEyeresearchassociationMemberoftheEuropeanSocietyofCataractandRefractiveSurgeonsMemberoftheBritishSocietyofCataractandRefractiveSurgeonsMemberofNorthernIrelandRecognisedResearchGroupofInfectiousDiseasesMemberofNorthernIrelandRecognisedResearchGroupofVisionScienceMemberofBowmansClubMemberoftheRCOscientificcommitteeMemberofOcularTissueAdvisoryGroupUKMemberofOcularTissueAdvisoryGroupsubgroupResearchAuditClinicalGovernance,UKMemberofRoyalCollegeofOphthalmologyResearchCommitteeMemberofCouncilforUKISCRIS2012CommitteeMemberforBSc.Hons.Optometry,UniversityofUlsterInternational Advisory Committee member (invited) for the 2nd European Workshop onPersonalisedHealthUKMemberofOcularTransplantGroupSubcommitteeResearch&AuditExternalExaminerforIrishCollegeofOphthalmologyUKISCRSCouncilMemberfinishedtenureInvitedPresentationsMy research is presented at peer-reviewed internationally established conferences in Ireland,UK,Europe,USA,IndiaandUnitedArabEmirates.BMECBirminghamAlumni 2015BSRS 2015TrendsinOphthalmology40thAnnualMeeting 2015CrosslinkingconferenceGeneva 2015BSRS 2014UKISCRS 20143rdAyrCataractSurgeryCourse,UniversityHospitalAyr 2013Invitedlecture,ImmunologyDepartment,UAEUniversity,AbuDhabi,UAE 2012XXXIAnnualConferenceoftheMaharashtraOphthalmologicalSociety&4thAnnualConferenceofPoonaOphthalmologicalSociety,India. 2011EachyearmyteamandIpresentatthelargesteyeconferenceintheworld;ARVO,USA.PostgraduateAwardsandPrizes2015 Revalidation ofUlsterUniversity Course CataractDiplomaCourse In Cataract and RefractiveSurgery2013Twonovelpatentsubmissions2013AwardedExceptionallyGoodReviewerforInvestigativeOphthalmologyandVisionScience2012 Team research on ‘Development of therapeutic siRNA for an epidermolysis bullosa simplexcausingmutationinkeratin’andpresentedbypost-doctoralresearcherattheIrishSocietyofHumanGenetics2013ScientificMeetingwasawardedthebestpost-doctoralposterprizeaward.2012Teamresearchon‘Assessmentofallele-specificgenesilencingsiRNAsinanexvivopre-clinicalmodel of lattice type I corneal dystrophy’ and presented by postgraduate researcher at the IrishSocietyofHumanGenetics2013ScientificMeetingwasawardedthe‘YoungInvestigatorAwardforBestPostgraduateOralPresentation’.20111yearmedicalstatisticscourse(withProfEGoodallQUB)2011Team researchpresentedbypost-doctoral researcherhasbeenhonouredwithaprestigiousaward recognising their work in the field of immunology. The 2011 Cora Verhagen Immunology

AwardwasgiventothebestpresentationofresearchattheAssociationforResearchinVisionandOphthalmology(ARVO)conferenceinFortLauderdale,Florida.2010NILTGforAnimalScientificProceduresCertificate(PersonalLicence)2009MostReadPaperawardedformanuscript,“Concordancebetweencommondryeyediagnostictests” ranked third in top 10 most read papers in the British Journal of Ophthalmologyhttp://bjo.bmj.com/reports/mfr1.dtl2008GoodClinicalPracticecourse2007 InternationalSocietyofOcularOncologybestposterpresentationprize. Iwassupervisorforthepostgraduatestudentawardedaprizefortheresearchentitled:P63expression inconjunctivalproliferativediseases.2004Grandfinalistandsecondprize25KScience&BusinessInnovationAward.2004 Applied for membership of The Institute for Learning & Teaching in Higher Education(ILTHE)/HigherEducationAcademy.2000 Richard Havelock Charles Scholarship & Medal, Queen’s University of Belfast ResearchFellowshipPrize2000 Patrick Trevor-Roper Travel Award Fund awarded from Royal College of Ophthalmologists,London2000BMAFilmCompetition-WinneroftheUKmultimediacategorywith:“Interactivevideoguidetoeyemovementdisorders”1997TheDr.JD.WilliamsonPrizeforbestresearchpaperfromQUBSurgicalExperienceCurrently my clinical practice consists of both NHS and private practice. In the NHS I have onegeneralclinic,oneanteriorsegmentspecialistclinicandonespecialistglaucomaclinic.DuetoNHSdemandmygeneralclinichasbecomepredominatelynowalsoananteriorsegmentclinic.MyNHSsurgery consists predominately of anterior segment cases in addition I do twice a month a highthroughput (25 per 5 hour session) cataract theatre session. I currently also take most of thereferrals for complexanterior segmentand cataract reconstructive cases for the trust. I regularlycarryout complex anterior segment reconstructive procedures particularly, DSEK, DMEK, andpenetrating keratoplasties, scleral & iris sutured IOLs, pupil reconstruction by suturepexy andartificial iris implants (morcher scleral/intracapsular and the silicone Human Optics), limbal andconjunctival stem cell transplantation. In addition I gained experience in the use of varioustechniques indealingwithanteriorsegmenttumours inAustraliaduringmyclinical fellowshipandcurrently provide this service within the Belfast trust. For the treatment of keratoconus I haveintroduced to the Royal Group of Hospitals: crosslinking, INTACs, anterior lamellar graftingtechniquesandtoricphakicIOLtreatmentsascombinationtreatmentstooptimisevisualacuitiesinthesepatients.IamcurrentlyworkingwiththeHospitalcommitteestoenableintroductionoftype1keratoprothesiscasesintotheRoyalGroupofHospitalsandtoseekfundingforimprovedmethodstoinvestigatecasesof infectiouskeratitis. Ihavealsorecentlydevelopedanovelanteriorsegmenttechnique to manage pterygium which has been published both as a case series and long-termfollow-up is tobepresented inASCRSnext year. I havebeenasked towrite a chapter on abookrelatingtothisnewtechnique.Iammedicaldirectorofaprivateclinic (CathedralEyeClinic)withinwhich I specialise incataract,lens based and laser refractive surgery. Currently I have a busy practice involving bothmultifocalIOLs, phakic IOLs and use the Schwind amaris excimer laser and more recently the VISUMAXfemtolaserwhichIhavenowbeensuccessfullyusingforsixmonths.Ihavepersonallycompletedintheregionof16,000cataractandrefractiveprocedures.

Every surgical case carried out is included from the pre to every postoperative stage in ourcomprehensive electronic audit system which I have personally created along with my chiefoptometrist and which comprises, documentation of any surgical complication, full visualassessment, refraction, aberrometry, topography, tomography, contrast sensitivity, stereopsis,subjective visual function testing. All of this documentation is designed to enable improvedunderstandingoftheinter-individualresponsestothedifferentIOLswhichareusedwithintheclinic.Totrytoenablethesurgeontobetterpredictanypatientwhomighthaveasuboptimaloutcome.Duringclinicalpostgraduatetraining Ihaveobtainedextensivesurgicalexperience inallaspectsofgeneral ophthalmology including cataract, anterior segment, glaucoma, squint, vitreo-retinalproceduresandlidsurgery.Ihadaspecificinterestinocularmotilitymanagementandthisresultedinmy creatinganelectronic teachingguide for this subspecialtyduringmy training (thiswon firstprizewithintheUKfromtheBMAteachingawardssection).SincethenIhaveintroducedandexpandedtherepertoireofrefractivecataractsurgicaltechniquesofferedbothintheBelfastTrustNHSpracticeandinCathedralEyeClinic.ResearchDisseminationTotalPapers100+

JournalArticles0+

hindex19

i10Index38

No ofcitations1530

SourceofdataScopus

Reviews2

CDRom2

BookChapters2Books1

ConferencePresentations120+

PeerReviewedPublications

1. SarahD.Atkinson,DavidG.Courtney,EdwinH.A.Allen,JohnnyE.Moore,LauraMairs,KatieChristie,DavideSchiroli,1EleonoraMaurizi,CianMcCrudden,DesmondArcher,DunJackFu,RobynP.Hickerson,M.AndrewNesbit,DeenaM.LesliePedrioli,W.H.IrwinMcLeanandC.B.TaraMoore.TherapeuticsiRNAandCRISPR/Cas9geneeditinginthecorneaofkeratin12-luciferasemultitargetknock-inmice.EMBOMolecularMedicine,2016.UnderReview

2. Mr Richard N McNeely BSc1,2, Dr Eric Pazo MD1,2, Mr Andrew Spence BSc1, Mr ZackMillar1,DrOlivierRichozMDPhD1,DrAndrewNesbitBA,PhD2,ProfessorTaraCBMoorePhD2 andProfessor Jonathan EMoorePhD FRCOphth 1,2Threshold limit of postoperativeastigmatismforpatientsatisfactionafterclearlensextractionandmultifocalintraocularlensimplantation.JournalofCataract&RefractiveSurgeryInpress.

3. JohnnyMoore, Davide Schiroli and TaraMoore. Potential Effects of Corneal Crosslinkingupon the Limbus. Latest TreatmentOption and Technology Advancement in Corneal andOcularSurfaceDisease2016.BioMedResearchInternational(2016)InvitedReview.Inpress

4. JohhnyMoore,EricPazo,RichardMcNeely,OlivierRichoz.OptimisedvisualoutcomeafterasymmetricalmultifocalIOLrotation.JournalofCataractandRefractiveSurgery.JournalofRefractiveSurgery(2016).Inpress.

5. Reinstein DZ et al. Efficacy, Safety, Contrast Sensitivity, Aberration Control and 2 yearstability after LASIK for high myopia and astigmatism from -8.00 to -14.25 D. Journal ofRefractiveSurgery(2016).Inpress.

6. Leccisotti A, Fields SV,Moore J, Shah S,Moore TC. Changes in ocular biomechanics afterfemtosecond laser creation of a laser in situ keratomileusis flap. J Cataract Refract Surg.2016Jan;42(1):127-31.

7. Allen EH, Courtney DG, Atkinson SD, Moore JE, Mairs L, Toftgaard Poulsen E, Schiroli D,Maurizi E, Cole C,HickersonRP, James J,MurgatroydH, Smith FJ,MacEwenC, Enghild JJ,

Nesbit MA, Leslie Pedrioli DM, McLean WH, Moore CB. Keratin 12 missense mutationinduces the unfolded protein response and apoptosis in Meesmann epithelial cornealdystrophy.HumMolGenet.2016Jan11.pii:ddw001.[Epubaheadofprint]

8. Olivier Richoz, Farhad Hafezi, Tara Moore, Johnny Moore. Corneal Cross-linking as anAdjuvant Therapy in the Management of Recalcitrant Deep Stromal Fungal Keratitis: ARandomizedTrial.AmJOphthalmol.2015.160(3).pp.616-617

9. CourtneyDG,MooreJE,AtkinsonSD,MauriziE,AllenEH,PedrioliDM,McLeanWH,NesbitMA,MooreCB.CRISPR/Cas9DNAcleavageatSNP-derivedPAMenablesbothinvitroandinvivoKRT12mutation-specifictargeting.GeneTher.2015Aug20.

10. HamadaS,MooreTC,MooreJE,Al-DreihiMG,AnbariA,ShahS.Assessmentoftheeffectofcyclosporine-A 0.05% emulsion on the ocular surface and corneal sensation followingcataract surgery. Cont Lens Anterior Eye. 2015 Aug 11. pii: S1367-0484(15)30014-X. doi:10.1016/j.clae.2015.07.003.[Epubaheadofprint]Aug2015

11. CourtneyDG,ToftgaardPoulsenE,KennedyS,MooreJE,AtkinsonSD,MauriziE,NesbitMA,MooreCB, Enghild JJ. ProteinCompositionof TGFBI-R124C- andTGFBI-R555W-AssociatedAggregates Suggests Multiple Mechanisms Leading to Lattice and Granular CornealDystrophy.InvestOphthalmolVisSci.2015Jul1;56(8):4653-61

12. Courtney DG, Atkinson SD, Allen EH, Moore JE, Walsh CP, Pedrioli DM, MacEwen CJ,Pellegrini G,Maurizi E, Serafini C, FantacciM, Liao H, Irvine AD,McLeanWH,Moore CB.siRNAsilencingofthemutantkeratin12alleleincorneal limbalepithelialcellsgrownfrompatientswithMeesmann'sepithelialcornealdystrophy.InvestOphthalmolVisSci.2014May6;55(5):3352-60.

13. Moore JE, Atkinson SD, Azar DT, Worthington J, Downes CS, Courtney DG, Moore CB.Protection of corneal epithelial stem cells prevents ultraviolet A damage during cornealcollagencross-linkingtreatmentforkeratoconus.BrJOphthalmol.2014Feb;98(2):270-4.

14. deWitD,DiazJ,MooreCBT,MoutariS,MooreJE(2014)Analysisoftheeffectofpositionofnear add in an asymmetric refractive LENTIS®Mplus LS-312multifocal intraocular lens onqualityofvision.JournalofCataractandRefractiveSurgery.Volume41,Issue5,May,Pages945–955.

15. McGilliganV,Moore JE, Atkinson SD,MooreCBT (2014)A Comparisonof the Clinical andMolecularDiagnosisofHerpesSimplexKeratitis.OpenJournalofOphthalmology.Vol4(3)

16. Courtney D.G., Atkinson, S.D., Allen, E.H.A.,Moore, J.E.,Walsh, C.P., Leslie Pedrioli, D.M.,Macewen, C.J., Pellegrini, G., Maurizi, E., Serafini, C., Fantacci, M., Liao, H., Irvine, A.D.,McLean,W.H.I., Moore, T.C.B. (2014). siRNA Silencing of theMutant Keratin 12 Allele inCorneal Limbal Epithelial Cells Grown from Patients with Meesmann’s Epithelial CornealDystrophy. Invest Ophthalmol Vis Sci. 2014 May 6;55(5):3352-60. doi: 10.1167/iovs.13-12957

17. DavidG.Courtney,SarahD.Atkinson,JonathanE.Moore,EleonoraMaurizi,ChiaraSerafini,Graziella Pellegrini, Graeme C. Black, Forbes Manson, Gary Hin-Fai Yam, Caroline J.MacEwen, Edwin H. A. Allen, William H. Irwin McLean, and Tara C. B. Moore (2014)DevelopmentofallelespecificgenesilencingsiRNAsforTGFBIArg124CysinLatticeCornealDystrophy Type I. Invest. Ophthalmol. Vis. Sci. January 14, 2014 IOVS-13-13279. DOI10.1167/iovs.13-13279.

18. JonathanEMoore,SarahDAtkinson,DimitriTAzar,JennyWorthington,CStephenDownes,DavidGCourtney,CBTaraMoore(2013)ProtectionofcornealepithelialstemcellspreventsUV-A damage during corneal collagen cross-linking treatment for keratoconus. Br JOphthalmoldoi:10.1136/bjophthalmol-2013-303816

19. McGilligan VE, Gregory-Ksander MS, Li D, Moore JE, Hodges RR, GilmoreMS, Moore TC,Dartt DA. Staphylococcus aureus Activates the NLRP3 Inflammasome in Human and RatConjunctival Goblet Cells. PLoS One. 2013 Sep 10;8(9):e74010. doi:10.1371/journal.pone.0074010.

20. JudithLechner,DurgaDash,DorotaMuszynska,MohsenHosseini,FaniSegev,SoniaGeorge,DavidFrazer,JohnnyMoore,StephenKaye,TerriYoung,DavidSimpson,AmandaChurchill,Elise Heon, and ColinWilloughby. Mutational Spectrum of the Zinc Finger E-box BindingHomeobox 1 (ZEB1) Gene in Corneal Dystrophies Supports a Genotype-PhenotypeCorrelation.IOVS2013May3;54(5):3215-23.doi:10.1167/iovs.13-11781

21. AllenEH,AtkinsonSD,LiaoH,Moore JE, LesliePedrioliDM,SmithFJ,McLeanWH,MooreCB. Allele-specific siRNA silencing for the common keratin 12 founder mutation inMeesmannepithelial cornealdystrophy. InvestOphthalmolVis Sci. 2013 Jan17;54(1):494-502

22. de Wit DW, Diaz JM, Moore TC, Moore JE. Refractive lens exchange for a multifocalintraocular lenswitha surface-embeddednear section inmild tomoderateanisometropicamblyopic patients. J Cataract Refract Surg. 2012 Oct;38(10):1796-801. doi:10.1016/j.jcrs.2012.06.046.Epub2012Aug21.

23. LeccisottiA,AslanidesIM,MooreJE,ShahS.Keratoconusandkeratoectasia:advancementsindiagnosisandtreatment.JOphthalmol.2012;2012:526058.Epub2012Feb29.

24. LiaoH, IrvineAD,MacEwenCJ,WeedKH,Porter L,CordenLD,GibsonB,Moore JE, SmithFJD,Moore CBT,McLeanWHI (2011) Development of allele-specific therapeutic siRNA inMeesmannepithelialcornealdystrophy.PLoSOne.2011;6(12):e28582.Epub2011Dec12

25. Eirini Skiadaresi; ColmMcAlinden; Giuseppe Ravalico; JonathanMoore. Optical coherencetomographymeasurementswiththeLENTISMplusmultifocalintraocularlens.GraefesArchClin Exp Ophthalmology 2012 Sep;250(9):1395-8. doi: 10.1007/s00417-011-1901-8. Epub2012Jan4.

26. JonathanEMooreandCBTaraMoore.DryEyeTestingInGlaucoma.Glaucoma.Volume7,Issue1.2011.

27. ClareG,Moore TC,Grills C, Leccisotti A,Moore JE, Schallhorn S. Early Flap DisplacementafterLASIK.Ophthalmology.2011Sep;118(9):1760-5.Epub2011May6

28. MooreJE,VaseyGT,DarttDA,McGilliganVE,AtkinsonSD,GrillsC,LameyPJ, LeccisottiA,Frazer DG,Moore TC. Effect of Tear Hyperosmolarity and Signs of Clinical Ocular SurfacePathology upon Conjunctival Goblet Cell Function in the Human Ocular Surface. InvestOphthalmolVisSci.2011Aug3;52(9):6174-80.Print2011.PubMedPMID:21519030.

29. Sharma, Anant; Sharma, Benjamin AR; Moore, Jonathan; Nolan, Matthew. Simple fingerprick freshblood technique foruseon theocular surface. ContactLensandAnteriorEye.201134(1);49

30. McAlinden,Colm;McCartney,Mark;Moore,Jonathan.MathematicsofZernikepolynomials:areview.Clinical&ExperimentalOphthalmology.201139(8);820-827

31. McAlinden, Colm; Skiadaresi, Eirini; Moore, Jonathan; Pesudovs, Konrad. Subscaleassessment of the NEI-RQL-42 questionnaire with Rasch analysis. InvestigativeOphthalmology&VisualScience.201152(8);5685-5694.

32. McAlinden C, Skiadaresi E, Pesudovs K, Moore JE. Quality of vision after myopic andhyperopic laser-assisted subepithelial keratectomy. J Cataract Refract Surg. 2011 Apr 13;37(6):1097-1100

33. McAlindenC,SkiadaresiE,MooreJE.Visualandrefractiveoutcomesfollowingmyopiclaser-assistedsubepithelialkeratectomywithaflying-spotexcimer laser. JCataractRefractSurg.2011Mar14;37(5):901-906MooreJE.

34. McAlinden C,Moore J.Multifocal intraocular lenswith a surface-embedded near section:Short-term clinical outcomes. J Cataract Refract Surg. 2011 Mar; 37 (3) :441-5. PubMedPMID:21333867.

35. McAlinden C, Moore J. Laser-assisted subepithelial keratectomy retreatment surgery. JCataractRefractSurg.2011Feb;37(2):358-63.PubMedPMID:21241921.

36. McAlindenC,Moore JE.Retreatmentof residual refractiveerrorswith flap lift laser insitukeratomileusis.EurJOphthalmol.2011Jan-Feb;21(1):5-11.PubMedPMID:20602327.

37. McAlindenC,Moore JE. The change in internal aberrations followingmyopic corneal laserrefractivesurgery.GraefesArchClinExpOphthalmol.2011Jul31.249(5):775:781

38. McAlindenC,PesudovsK,MooreJE.Thedevelopmentofaninstrumenttomeasurequalityof vision; the Quality of Vision (QoV) questionnaire. Invest Ophthalmol Vis Sci. 2010Nov;51(11):5537-45

39. McAlinden C, Moore JE, McGilligan VE, Moore TC. Spherical aberration and higher orderaberrationswithBalafilconA(PureVision)andComfilconA(Biofinity).GraefesArchClinExpOphthalmol.2010:249(4):607-612

40. McAlindenC,SkiadaresiE,MooreJE.HyperopicLASEKTreatmentswithMitomycinCUsingtheSCHWINDAMARIS.JRefractSurg.2010Nov5:1-4;27(5)380

41. McAlinden C, Moore JE. Higher Order Aberrations Using the NIDEK OPD-Scan and AMOWaveScan.JRefractSurg.2010Apr28:1-4.26(8);605

42. McAlindenC,MooreJE.ComparisonofhigherorderaberrationsafterLASIKandLASEKformyopia.JRefractSurg.2010Jan;26(1):45-51.

43. Reynolds A, Moore JE, Naroo SA, Moore CB, Shah S. Excimer laser surface ablation - areview.ClinExperimentOphthalmol.2010Mar;38(2):168-82

44. deWitD,AthanasiadisI,SharmaA,MooreJ.Suturelessandglue-freeconjunctivalautograftinpterygiumsurgery:acaseseries.Eye(Lond).2010Jun4.24(9);1474-1477.

45. Graham,JE.,McGilligan,V,Berrar,D,Leccisotti,A,Moore,JE.,Bron,AJ.andMoore,T(2009)AttitudestowardsDiagnosticTestsandTherapiesforDryEyeDisease.OphthalmicResearch,43(1).pp.11-17.

46. Novitskaya,ES.,Dean,SJ.,Moore,JE.,Moore,T,Nagendran,SandSharma,A(2009)Effectsof some ophthalmic medications on pupil size: a literature review. Canadian Journal ofOphthalmology–JournalCanadienDOphthalmologie,44(2).pp.193-197.

47. Goodall, E. A.,Moore, J. andMoore, T (2009) The estimation of approximate sample sizerequirements necessary for clinical and epidemiological studies in vision sciences. EYE, 23(7).pp.1589-1597.

48. Sharma A, Moore JE. Autologous fibrin glue for pterygium surgery with conjunctivalautograft.ContLensAnteriorEye.2009Jul18.32(5);209

49. Novitskaya ES, McGilligan VE, Moore J, Sharma A, Dean S, Moore T. Difficulties imagingHerpes Simplex Keratitis with FITC labelled anti- HSV-1 antibodies in an ex-vivo model.Cornea2009;28:421-425

50. Graham JE, Moore JE, Goodall EA, Dartt DA, Leccisotti A, McGilligan VE, Moore TC.Concordancebetweencommondryeyediagnostictests.BrJOphthalmol2009;93:66-72

51. Novitskaya,E.S.,Moore,J.E.,Athanasiadis,Y.,Moore,TaraandSharma,A.(2008)Ahighlysensitive technique for imaging and effectivemonitoring of staining of the ocular surfacedefects.EYE,23(1).pp.234-235.

52. McAlinden,Colm;Moore,Jonathan.KeratoconusI.OptometryToday.200848(12);43-4753. Dean SJ, Novitskaya ES, Moore CBT, Moore JE, Sharma A. Documentation of corneal

epithelialdefectswithfluoresceinenhanceddigitalfunduscameraphotography.ClinicalandExperimentalOphthalmology2008;36(2):113-8.

54. Atkinson SD, Moore JE, Shah S, Sharma S, Best RM, Leccisotti A, Alarbi M, Rimmer D,GardinerT,MooreCBT.P63expressioninconjunctivalproliferativediseases:pterygiumandLOCsyndrome.CurrEyeRes2008;33(7):551-8.

55. Novitskaya ES, Moore JE, Dean SJ, Athanasiadis Y, McGilligan VE, Moore T, Sharma A.Imaging the epithelial defects of the ocular surface with digital fundus camera usingfluoresceinangiographysettings.Cornea2008.

56. Graham JE,Moore JE,McClurgB,MooreCBT.Cross contaminationofhospitalophthalmicslitlampsbyocularbacteria.AmericanJournalofInfectionControl2008;36(8):605-6.

57. Graham JE, Graham RLJ, Beirne R, McGilligan VE, Downes CS, Moore JE, Moore CBT,McMullan G. The use of conjunctival swab for the proteomic characterisation of Dry EyeSyndrome.JournalofProteomicsandBioinformatics2008;1:20-33.

58. Novitskaya ES, Dean SJ, Moore JE, Moore CBT, Sharma A. A novel method to studyfluorescein staining of the ocular surface using the fluorescein angiogram setting of thefunduscamera.ContLensAnteriorEye.2007Sep;30(4):258-9.

59. GrahamJE,MooreJE,JiruX,MooreJE,GoodallEA,DooleyJSG,HayesV,DarttDA,DownesSC&MooreCBT.OcularPathogenorCommensal:APCRBasedStudyof SurfaceBacterialFlorainNormalandDryEyes.InvestigativeOphthalmology&VisualScience.2007;48:5616-5623.

60. Kaji Y, Usui T, Ishida S, Yamashiro K, Moore CBT, Moore JE, Yamamoto Y, Yamamoto H,Adamis AP. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with asoluble form of a receptor for advanced glycation end products. InvestigativeOphthalmology&VisualScience.2007Feb;48(2):858-65.

61. Antonio Leccisotti, MD, PhD, Johnny Moore, FRCOphth, PhD. Haze after photorefractivekeratectomycausedbyiatrogeniclagophthalmos.JCRS2006.32(8);1392-1394.

62. Boutboul S, Black GC,Moore JE, Sinton J, MenascheM,Munier FL, Laroche L,AbitbolM,SchorderetDF.AsubsetofpatientswithepithelialbasementmembranecornealdystrophyhavemutationsinTGFBI/BIGH3.HumMutat.2006Jun;27(6):553-7

63. TanMH, Bryars J,Moore JE. Use of nerve growth factor to treat congenital neurotrophiccornealulceration.Cornea.2006Apr;25(3):352-5

64. MooreJE,ShahS,KumarV,AinsworthJR,PageAB,McLeanWH.FollowupofpatientswithocularscarringsecondarytoLOCsyndrometreatedbyamnioticmembranetransplantation.BrJOphthalmol.2005Aug;89(8):939-41.

65. JEGraham,JEMoore,JXu,JEMoore,RMBest,ABPage,SDAtkinson,DMSmall,JSGDooley,CLowry,DDartt,CSDownes,CBTMoore.Analysisofbacterialfloraindryeye.TheOcularSurface2005.3:568.

66. Moore JE. A cataract decision support system: its requirement is increasing. Studies inhealthtechnologyandinformatics.2005117;147

67. Moore JE, Herath GD & Sharma A. Continuous curvilinear capsulorrhexis with use of anendoscope.JCataractRefractSurg.2004May;30(5):960-3.

68. V Kumar, JMoore,W Ilahi, SMantry, S Shah, PMcDonnell. Endothelial Cell Density andContrastSensitivityinPatientsafterDeepLamellarKeratoplasty.InvestigativeOphtalmologyandVisualScience.2004.45(5):2906

69. Moore JE, Herath G. & Sharma A. Endoscopic visualisation to aid deep anterior lamellarkeratoplasty.Eye.2004Feb;18(2):188-91.

70. McLeanWHI,IrvineAD,HamillKJ,WhittockNV,Coleman-CampbellCM,MellerioJE,AshtonGS,Dopping-HepenstalPJ,EadyRA,JamilT,PhillipsRJ,ShabbirSG,HaroonTS,KhurshidK,MooreJE,PageAB,DarlingJ,AthertonDJ,VanSteenselMA,MunroCS,SmithFJ.&McGrathJA. An unusual N-terminal deletion of the laminin {alpha}3a isoform leads to the chronicgranulationtissuedisorderlaryngo-onycho-cutaneoussyndrome.HumMolGenet.2004Feb1;13(3):365.

71. UsuiT.IshidaS.YamashiroK.KajiY.PoulakiV.MooreJ.MooreCBT.AmanoS.HorikawaY.Dartt D. GoldingM. Shima DT. & Adamis AP. VEGF164 (165) as the pathological isoform:differentialleukocyteandendothelialresponsesthroughVEGFR1andVEGFR2.InvestigativeOphthalmology&VisualScience.2004Feb;45(2):368-74.

72. Moore JE, Kumar V & S Shah. Treatment of the complications of LOGIC syndrome usingamnioticmembrane.Avideoguide.ElectronicBritishJournalofOphthalmologyDec2003.

73. MooreCBT,MooreJE,KajiY,FrizzellN,UsuiT,PoulakiV,CampbellIL,StittAW,GardinerTA,Archer DB. & Adamis AP. The role of advanced glycation end products in retinalmicrovascularleukostasis.InvestOphthalmolVisSci.2003Oct;44(10):4457-64.

74. YKaji,SAmano,TOshika,TUsui,KYamashiro,SIshida,TMcMullen,JMoore,APAdamis,SHoriuchi. Advanced Glycation End Products Produce Induce Apoptosis in CornealEndothelium.InvestigativeOphtalmologyandVisualScience.200344(5):4715

75. McLeanWHI,IrvineAD,HamillKJ,WhittockNV,Coleman-CampbellCM,MellerioJE,AshtonGS, Dopping-Hepenstal PJ, Eady RA, Jamil T, Phillips RJ, Shabbir SG, Haroon, Moore JE.McMullen TCB. Mahon G. & Adamis AP. The Corneal Epithelial Stem Cell. (DNA & CellBiology,Focused issueonTheMolecularPathogenesis&InflammationofOcular InfectiousDiseases2002May21:5/6p443-451.

76. Moore JE,McMullen CBT, Campbell IL. Rohan R. Afshari NA, Kaji Y. Usui T. Archer DB. &Adamis AP. The Inflammatory Milieu Associated with Conjunctivalised Cornea and itsAlterationusingIL-1RATransfectionInvestigativeOphthalmology&VisualScience2002Feb43:9p2905-2915.

77. MooreJE&SharmaA.Endoscopicvisualisationtoaidposteriorcornealandcapsulorrhexissurgery:-avideoguide.ElectronicBritishJournalofOphthalmology,Jan2003.

78. IrvineAD,MooreJE,ColemanC,SwenssonO,MorganS,McCarthyJ,SmithFJD,BlackGCM&McLeanWHI. AnovelmutationinKRT12associatedwithMeesmann'sepithelialcornealdystrophy.Br.JOphthalmol.200286(7):729-32.

79. TBMcMullen,NFrizzell, JEMoore,VPoulaki, ILCampbell,NAAfshari,YKaji,AWStitt,DBArcher,APAdamis.Amodulatoryroleforadvancedgylcationend-products(AGEs)inretinalmicrovascular leukostasis. Investigative Ophtalmology and Visual Science. 2002 43(12):1348.

80. MooreJE,DuaHS,PageAB,IrvineAD&ArcherDB.OcularSurfacereconstructioninLOGICsyndromebyAmnioticMembraneTransplantation.Cornea200120(7):753-756.

81. NichollID,StittAW,MooreJE,RitchieAJ,ArcherDB&BucalaR.Increasedlevelsofadvancedglycationendproductsinthelensesandbloodvesselsofcigarettesmokers.MolMed.19984(9):594-601.

82. StittAW,MooreJE,SharkeyJA,MurphyG,SimpsonDAC,BucalaR,VlassaraH&ArcherDB.(1998)Advancedglycationendproducts in vitreous: Structural and functional implicationsfordiabeticvitreopathy.InvestigativeOphthalmology&VisualScience,199839(13):2517-23.

83. IrvineAD,CordenLD,SwenssonO,SwenssonB,MooreJE,FrazerDG,SmithFJ,KnowltonRG,ChristophersE,RochelsR,UittoJ&McLeanWHI.‘Mutationsincorneal-specifickeratinK3orK12cause-Meesmann’scornealdystrophy’NatureGenetics,199716(2):184-7.

NonPeerReviewedPublications

1. ShahS,McAlindenC,LeccisottiA,MooreJE,McConvilleD,MooreT.ClinicalGovernance&MedicolegalIssues.CataractandrefractivesurgerytodayEurope,2009;Sept:83-84

2. ShahS,McAlindenC,LeccisottiA,MooreJE,McConvilleDandMooreCBT.ComplicationsofRefractive Surgery. Cataract and Refractive Surgery 2009;4(2):68-69 (impact factor: 2.064;Ranked17outof49inophthalmology;4*)

3. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Cataract SurgeryCoursework.CataractandrefractivesurgerytodayEurope,2009;May:77-79

4. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Correction ofPresbyopia.CataractandrefractivesurgerytodayEurope,2009;March:69-73

5. ShahS,McAlindenC,LeccisottiA,MooreJE,McConvilleD,MooreT.Reviewoftwocourses:correcting regular and irregular astigmatism, phakic IOLs. Cataract and refractive surgerytodayEurope,2008;3(7):92-64.

6. ShahS,McAlindenC,LeccisottiA,MooreJE,McConvilleD,MooreT.Excimerlaserrefractivesurgery.CataractandrefractivesurgerytodayEurope,2008;3(5):61-63.

7. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Preoperativeassessment in refractivesurgery.Cataractandrefractivesurgery todayEurope,2008;3(4):76-78.

8. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Past and presentrefractivetechniques.CataractandrefractivesurgerytodayEurope,2008;3(3):80-82.

9. Shah S,Moore JE, Leccisotti A,McConville D,Moore CBT, Cataract, Refractive E-LearningCourseCataractandrefractivesurgerytodayEurope,2008;3(2):83-85

10. ShahS.LeccisottiA.MooreJE.MooreCBT.ELearningcouldsolveRefractiveSurgeryTrainingDilema.AimingforWorldwideExcellenceinCataractandRefractiveSurgery.OphthalmologyTimesEurope.November1p29-302007Editionwww.ophthalmologytimes.com

AbstractsfromConferenceProceedings

1. MooreJE,MurphyMF&SilvestriG.ACaseofAcquiredOcularToxoplasmosis,IrishJournalofMedicalScience:Vol163No10.1994

2. LoteryA,Moore JE& JohnstonPB.Reviewof3rd, 4thand6thCranialNervePalsies, IrishJournalofMedicalScience:Vol163No1.1994

3. MooreJE,&SilvestriG.RetinalVasculitisassociatedwithGranulomaAnnulare,IrishJournalofMedicalScience:Vol165No1.1996

4. McLeanWHI,CordenLD,IrvineAD,MooreJE,FrazerDG,SwessonO,SwessonB,SmithFJD,KnowltonRG,ChristophersE,RochelsR&UittoJ.Meesmann’scornealdystrophyiscausedbymutationsincornea-specifickeratinsK3orK12,AmericanJournalofHumanGenetics,61(suppl4):99.1997

5. Corden L, Irvine A, Swesson O, Swesson B, Moore JE, Frazer D, Smith F, Knowlton R,ChristophersE,RochelsR,UittoJ&McLeanWHI.Meesmann’scornealdystrophyiscausedbydominantnegativemutations incornea-specifickeratinsK3orK12. JournalofMedicalGenetics;34(s18).1997

6. Moore JE, StittAW, SimpsonDAC, Sharkey J, EarlyO,VlassaraH.&ArcherD.B.Advancedglycation end product formation on the vitreous collagen network is increased duringdiabetesandhyperglycaemia.DiabeticMedicine.1997

7. StittAW,MooreJE,SharkeyJA,MurphyG,SimpsonDAC,VlassaraH&ArcherDB.Structuraland functional role for advanced glycation end products in vitreous: Implications fordiabetesandageing.InvestOphthalmolVisSci34(9)577.1998

8. MooreJE,DuaHS,PageAB&ArcherDB.OcularSurfacereconstructioninLOGICsyndromeby Amniotic Membrane Transplantation. Association for Research in Vision &Ophthalmology.2001

9. McMullenCBT,MooreJE,KajiY,FrizzellN,UsuiT,PoulakiV,Campbell IL,AfshariNA,StittAW,ArcherDB&AdamisAP.TheRoleofAdvancedGlycationEnd-Products(AGEs)inRetinalMicrovascularLeukostasis.InvestigativeOphthalmology&VisualScience.2002

10. AfshariNA,McMullenCBT,MooreJE,CampbellIL,UsuiT,HaskovaZ,KasanderB&AdamisAP. Corneal Gene Therapy with IL-1 RA Inhibits Corneal Neovascularisation & SuppressesRejectioninPenetratingKeratoplasty.InvestigativeOphthalmology&VisualScience.2002

11. The InflammatoryMilieuAssociatedwithComjunctivalisedCorneaand ItsAlterationUsingIL-1RAGeneTherapy.Moore JE,McMullenCBT,Campbell IL,RohanR,AfshariNA,Kaji Y,UsuiT,ArcherDB&AdamisAP.InvestigativeOphthalmologyandVisualScience.2002

12. NarooS,KumarV,MooreJE,MallonEH,CunliffeIA,ShahS&BensonMT.ClinicalExperiencewiththe1CUAccommodativePosteriorChamberIntraocularLens.AssociationofCataract&RefractiveSurgery2003

13. Kumar V, Moore JE, Prydal J, Sharma A &.Shah S. Microkeratome Assisted AutomatedAnteriorandPosteriorLamellarKeratoplasties.AssociationofCataract&RefractiveSurgery.2003

14. KumarV,MooreJE,FisherAC, IskanderR,KennedyV,BatterburyM,KayeSB, NarooS&Shah S. Identification of Refractive Surgery Eyes Using Systematic Classification CornealTopographic Data by Fourier Series and Zernike Polynomials. Association of Cataract &RefractiveSurgery.2003

15. Moore JE, Kumar V, Zaman M, Naroo S & Shah S. Initial Results with Mobile WavelightAllegrettoExcimerLaser.AssociationofCataract&RefractiveSurgery.2003

16. MooreJE,SmallDM,GrahamJE,AtkinsonSD,MeenanBJ,LuiC,DownesCS&MooreCBT.Ocularcellgrowth,proteinabsorption&cytokineexpressionanalysisonmodifiedsurfaces,UK Society for Biomaterials, 3rd Conference and postgraduate dayUniversity of Brighton.2004

17. GrahamJE,MooreJE,XuJ,MooreJE,BestRM,PageAB,AtkinsonSD,SmallDM,DownesCS&MooreCBT.Comparisonofroutinebacteriologyculturetomoleculardetectionmethodsforanalysisofocularbacterialflora.The4thinternationalconferenceonthelacrimalgland,tearfilm,ocularsurfaceanddryeyesyndrome:BasicScienceandclinicalrelevance.2004

18. MooreJE,SmallDM,GrahamJE,AtkinsonSD,MeenanBJ,LuiC,DownesCS&MooreCBT.Ocularcellgrowth,proteinabsorption&cytokineexpressionanalysisonmodifiedsurfaces,JournalforResearchinExperimentalandClinicalOphthalmology,OphthalmicResearch,Vol36s1p1467.2004

19. Moore JE & Sharma A. The effect of changing phacoemulsification tips on cornealendothelialcellsESCRS.2004

20. Moore, Johnny, Small, DM, Graham, JE, Atkinson, Sarah, Meenan, BJ, Lui, C, Downes,Stephen and Moore, Tara The effect of atmospheric plasma surface treatment of poly(methyl methacrylate) MMA on corneal epithelial cell growth, protein absorption andcytokine expression. In: European Association for Vision & Eye Research, Vilamoura,Portugal.JournalforResearchinExperimentalandClinicalOphthalmology.Vol36(S1)1pp.2004

21. Moore, Johnny, Small, DM, Graham, JE, Atkinson, Sarah, Meenan, BJ, Lui, C, Downes,Stephen and Moore, Tara The effect of atmospheric plasma surface treatment ofpoly(methylmethacrylate)PMMAoncornealepithelialcellgrowthandproteinabsorption.In:UKSociety forBiomaterials,UniversityofBrighton.OphthalmicResearch.Vol36 (S1)1pp.2004

22. Moore JE, Rooney N, McGimpsey S, Shah S. To evaluate the effect of on-axis arcuatekeratotomies in phacoemulsificationon reducing preoperative corneal astigmatismand topredicttheastigmaticoutcomeoftheincisions.ASCRS.2005

23. MooreJE,RooneyN,McGimpseyS,ShahSToevaluatetheeffectoncornealastigmatismofusing an injected IOLcomparedtoa folded IOL.Todeterminewhethereither IOL typeorhapticpositionresultedinvariationinlevelsofintraocularastigmatism.ASCRS.2005

24. Moore JE, Rooney N, McGimpsey S, Shah S The effect of on-axis corneal incisions inphacoemulsificationonpostoperativecornealandmanifestastigmatismdependentontheaxisofcornealincision.ASCRS2005

25. ShahS,YeungI,MooreJ,MantryS.HigherOrderAberrations&AsphericAblationResultsfortheNidekEC5000CXIIASCRS.2005

26. JE Graham, JEMoore, DADartt, R Best,MAlarbi, SMcGimpsy, Y Diebold, CS Downes, JEMoore&TMoore. OcularSurfaceBacterialFlora–AConundrum. (abstract) InternationalConferenceEuropeanAssociationforVisionandEyeResearch(EVER),ActaOphthalmologicaScandinavicaVolume84,October2006,Suppl239.2006

27. JEGraham,JEMoore,DADartt,RBest,MAlarbi,SMcGimpsey,YDiebold,CSDownes,CBTMoore. Staphylococcus epidermidis: Friend or Foe in Dry Eye, its Interaction withConjunctival Goblet Cells. (abstract) International Conference European Association forVision and Eye Research (EVER). Acta Ophthalmologica Scandinavica Volume 84, October2006,Suppl239.2006

28. JEMoore,JEGraham,DADartt,EAGoodall&CBT.Moore.Whichismoredifficult:theTesttoUseortheDiagnosisofDryEye.(abstract)InternationalConferenceEuropeanAssociationforVisionandEyeResearch(EVER).ActaOphthalmologicaScandinavicaVolume84,October,Suppl239.2006

29. JE.Graham, JE.Moore,X Jiru, JE.Moore,EGoodall, JDooley,DA.Dartt,SC.Downes,TCB.Moore. Pathogen or commensal: a pcr based study of ocular surface bacterial flora innormal and dry eyes. (abstract) 5th International Conference, tear film & ocular surface:basicscienceandclinical relevance,TFOS.ActaOphthalmologicaScandinavica.Volume85,September2007;Suppl240.2007

30. JEMoore,JEGraham,EGoodall,DADartt,ALeccisotti,SCDownes,TCBMoore.Correlationbetweendiagnostictestsguidesthedevelopmentanduseofadryeyediagnosticalgorithm.(abstract)5thInternationalConference,tearfilm&ocularsurface:basicscienceandclinicalrelevance, TFOS. Acta Ophthalmologica Scandinavica Volume 85, September, Suppl 240.2007

31. VEMGilligan,JE.Graham,JEMoore,GMcMullan,RLJGraham,ROBeirne,SC.Downes,TCB.Moore. Proteomic analysis of conjucntival swab by mass spectrometry. (abstract) 5thInternational Conference, tear film & ocular surface: basic science and clinical relevance,TFOS.ActaOphthalmologicaScandinavica,Volume85,September,Suppl240.2007

32. JE MOORE, JE GRAHAM, RO BEIRNE, SC DOWNES and CBT MOORE . The effect ofpostoperative antibiotics on the ocular surface bacterial flora in cataract patients ActaOphthalmologicaScandinavicaVolume85September,Suppl240.

33. 2007McGilliganVE,GrahamJE,MooreJE,McMullanG,GrahamRLJ,BeirneRO,DownesCS,MooreTCB.Proteomicanalysisofconjucntivalswabbymassspectrometry.EVER,Slovenia.(poster presentation) Acta Ophthalmologica Scandinavica, Volume 85, September, Suppl240.2007

34. McGilliganVE,NovitskayaES,MooreJE,SharmaA,DeanSJ,MooreTC.Difficulties imagingherpessimplexkeratitiswith fluorescein isothiocynate-labelledanti-HSV-1antibodies inanex vivo model. Vision Science RRG Annual Meeting, Ballymena, N. Ireland (2007) (posterpresentation)Cornea.28(4):421-5.2009

35. McGilliganVE,NovitskayaES,MooreJE,SharmaA,DeanSJ,MooreTC.Difficulties imagingherpes simplex keratitiswith fluorescein isothiocynate-labeled anti-HSV-1 antibodies in anex vivo model. Infectious Diseases RRG Annual Meeting, Ballycastle, N. Ireland (posterpresentation)Cornea.2009May;28(4):421-5.2009

36. JonathanE.Moore,DarleneA.Dartt,GilbertT.Vasey,VictoriaE.McGilligan,SarahAtkinson,ClaireGrills,PhilipJ.LameyandTaraC.Moore.EffectofIncreasingTearOsmolarityandDryEyeSeverityonGobletCellPopulationintheHumanOcularSurface.InvestOphthalmolVisSci2011;52:E-Abstract3788.2011

37. Atkinson, Sarah, McGilligan, Victoria, Moore, Johnny, Tallouzi, M, Feeney, S, Sharma, A,Shah, S, Jackson, JA, Frazer, DG andMoore, Tara (2011) A comparison of the clinical andmolecular diagnosis of herpes simplex keratitis. In: ARVO, Fort Lauderdale. InvestOphthalmolVisSci.Vol52(6630)1pp.2011

38. Gilbert T. Vasey, Jonathan E. Moore, Victoria E. McGilligan, Sarah D. Aktinson, StephenFarrell,ClaireGrillsandTaraC.Moore.AComparisonOfDryEyeDiagnosticTestsWithinAnOptometricPopulation.InvestOphthalmolVisSci2011;52:E-Abstract3859.2011

39. TaraC.Moore,HaihuiLiao,Alan Irvine,LouiseF.Porter,BethanyGibson,LauraD.Corden,Carrie J. MacEwen, Kathryn H. Weed, Jonathan E. Moore and William H. McLean.Development of Allele-specific Therapeutic siRNA In Meesmann Epithelial CornealDystrophy.InvestOphthalmolVisSci2011;52:E-Abstract1113.2011

40. McGilligan, VE, Gregory, MS, Moore, Tara, Moore, Johnny, Hodges, RR and Dartt, DAExpressionofNALP3inflammasomecomponentsinhumanandratconjunctivalgobletcells.In:ARVO,FortLauderdale,Florida,USA.IOVS.Vol52(4788)1pp.2011

41. Moore,Johnny,Vasey,GT,Dartt,DA,McGilligan,Victoria,Atkinson,Sarah,Grills,C,Lamey,PJ, Leccisotti, A, Frazer, DG, Twaih, S andMoore, Tara Effect of tear hyperosmolarity andsignsofclinicalocularsurfacepathologyuponconjunctivalgobletcellfunctioninthehumanocular surface. In: Irish College of Ophthalmologists Annual Conference, Cavan, Ireland.InvestOphthalmolVisSci.1pp.2011

42. Moore, Tara, Liao, H, Irvine, AD, MacEwen, CJ, Weed, KH, Porter, L, Corden, LD, Moore,Johnny andMcLean,WHI Development of allele-specific therapeutic siRNA inMeesmannepithelialcornealdystrophy.In:IrishCollegeofOphthalmologistsAnnualConference,Cavan,Ireland.InvestOphthalmolVisSci.1pp.2011

43. DorotaMuszynska,JudithLechner,DurgaP.Dash,JonathanE.Moore,DavidA.Simpson,andColinE.Willoughby.FunctionalAnalysesandExpressionProfilingofKeratoconicKeratocytesHarbouring a Heterozygous Missense Mutation in the Zinc Finger E-box binding gene 1(ZEB1)ARVOMeetingAbstractsMarch26,201253:4220.2012

44. DavidGCourtney,SarahDAtkinson,JohnnyEMoore,EleonoraMaurizi,GraziellaPellegrini,Graeme C Black, Forbes DManson, Gary Hin-Fai Yam, IrwinWMcLean, Tara C BMoore;DevelopmentofallelespecificgenesilencingsiRNAsforTGFBIArg124CysinLatticeCornealDystrophyTypeI.Invest.Ophthalmol.Vis.Sci.2014;55(13):4069.2014

45. JohnnyEMoore,DavidGCourtney,SarahDAtkinson,EleonoraMaurizi,AndrewMNesbit,GraziellaPellegrini,DimitriTAzar,IrwinWMcLean,TaraCBMoore;Identifyingtheroleofmatrix metalloproteinases in the pathomechanism of TGFBI Arg124Cys related LatticeCornealDystrophyTypeI.Invest.Ophthalmol.Vis.Sci.2014;55(13):1011.2014

46. Tara Moore, Sarah Atkinson, Edwin Allen, Jonathan Moore, David Courtney, EleonoraMaurizi,AndrewNesbit,IrwinMcLean,DeenaLesliePedrioli;InvivogenesilencingbysiRNAdelivery to the corneal epithelium in a keratin-12- bioluminescencemousemodel. Invest.Ophthalmol.Vis.Sci.2015;56(7):1090.2015

OralPresentations1. Complications associated with Retained Posterior Segment Intraocular Foreign Bodies,

OphthalmologyAlumniMeeting,RoyalVictoriaHospital,Belfast.19942. RetinalVasculitisAssociatedwithGranulomaAnnulare,OphthalmicSectionMeeting,Royal

AcademyofMedicine,Ireland.19943. Characteristics of Behcets Disease in Ireland, North and South Irish College of

OphthalmologistsMeeting.19954. Retinal Vasculitis andGranulomaAnnulare anAssociation?Ophthalmic SectionMeeting,

RoyalAcademyofMedicine(Ireland).19955. AdvancedGlycationEndProductFormationon theVitreousCollagen is IncreasedDuring

Diabetes,BicentinaryAlumniMeeting.19976. Mutations in Cornea-Specific Keratins cause Meesmann’s Dystrophy, XXIII European

CorneaConference.19977. Meesmann’s Corneal Dystrophy Further Elucidated, Joint European ResearchMeeting in

OphthalmologyandVision.19978. ThegeneticbasisofMeesmann’sCornealDystrophy,BritishHumanGeneticsConference,

London.19979. Meesmann’s corneal dystrophy is caused bymutations in cornea-specific keratins K3 or

K12, 47th Annual Meeting of The American Society of Human Genetics, Baltimore,Maryland.1997

10. MeesmansCornealDystrophyitsGeneticBasisBowmansClub.199711. Naked Gene Transfer to the Corneal Epithelium. Annual Meeting of Research Fellows,

HarvardMedicalSchool,Boston,USA.2001

12. Inflammatory Milieu Associated with Conjunctivalised cornea. Schepen’s Eye ResearchInstitute,HarvardMedicalSchool,Boston.2001

13. Inflammatory Milieu Associated with Conjunctivalised cornea, invited lecture to theDepartmentofGenetics,NinewellsHospital,DundeeUniversity,Dundee.2001

14. The Inflammatory Environment Associated with Limbal Stem Cell Deficiencies, invitedlecture,BirminghamEyeHospital.2002

15. PosteriorLamellarGraftingforEndothelialAbnormalitiesBowmansClubBristol200216. OcularsurfacereconstructionwithamnioticmembraneinLOGICsyndromeBristol200217. The Limbal Stem Cell Invitation lecture to the stem cell group, University of Edinburgh.

200318. Those who wish to succeed must ask the right preliminary questions. Invited lecture

DepartmentofOphthalmology,CambridgeUniversity,Cambridge.200319. OutcomesfromAutomatedPosteriorLamellarGrafting,AlumniDay,RVH,Belfast.200320. Ocularcellgrowth,proteinabsorptionandcytokineprofileanalysisonmodifiedsurfaces.

UKSocietyforBiomaterials,UniversityofBrighton200421. OcularPathology-bacteria?4th internationalconferenceonthe lacrimalgland, tear film,

ocularsurfaceanddryeyesyndrome:BasicScienceandclinicalrelevance.Fajardo,PuertoRico2004

22. The Analysis of Bacterial Flora In Dry Eye International Tear Film and Ocular SurfaceConferenceinPuertoRico.2004

23. Comparisonofroutinebacteriologyculturetomoleculardetectionmethodsforanalysisofocular bacterial flora. The 4th international conference on the lacrimal gland, tear film,ocularsurfaceanddryeyesyndrome:BasicScienceandclinicalrelevance,Fajardo,PuertoRico.2004

24. HerpesSimplexKeratitisResearchProjectRecognisedResearchGroupInfectiousDiseasesNI.2004

25. Theeffectofatmosphericplasmasurfacetreatmentofpoly(methylmethacrylate)PMMAon corneal epithelial cell growth, protein absorption and cytokine expression’.EuropeanAssociationforVision&EyeResearch,Vilamoura,Portugal.2004

26. Theeffectofatmosphericplasmasurfacetreatmentofpoly(methylmethacrylate)PMMAoncornealepithelial cell growth,proteinabsorptionandcytokineexpression’.UKSocietyforBiomaterials,3rdConference,UniversityofBrighton,UK.2004

27. Amniotic membrane reconstruction and follow-up of two cases of LOC syndromeBowmansClub.2005

28. Follow-up of Patients with Ocular Scarring Secondary to LOC Syndrome Treated byAmnioticMembraneTransplantation.7thAlumniRVHBelfast2005

29. Efficacyof an in-vivo antibodybased assay for thedetectionof herpes simplex keratitis.Ophthalmology7thAlumniMeetingBelfastRoyalVictoriaHospital,BelfastNI.2005

30. Ocular Surface Bacterial Flora - A Conundrum European Association for Vision and EyeResearch(EVER)InternationalConference,Portugal2006

31. Staphylococcus epidermidis: Friend or Foe in Dry Eye, its Interaction with ConjunctivalGoblet Cells European Association for Vision and Eye Research (EVER) InternationalConference,Portugal2006

32. Pathogenorcommensal:apcrbasedstudyofocularsurfacebacterialflorainnormalanddryeyes.InternationalTearFilmandOcularSurfaceConferenceinSicily.2007

33. Allele-specific siRNA therapy for epidermolysis bullosa simplex. British Society forInvestigativeDermatology,Edinburgh,Scotlandhttp://www.bsid.org.uk/meetings/annual/programme/index.asp2010

34. Expression of NALP3 inflammasome components in human and rat conjunctival gobletcells.ARVOFortLauderdale.2011

35. Mutation-specific siRNA therapy for a keratin disorder. Irish Society of Human GeneticsAnnual ScientificMeeting 3rd September 2012, Royal College of Surgeons in Ireland.2012

36. S10 Mutation-specific siRNA therapy for a keratin disorder. Irish Society of HumanGenetics Annual Scientific Meeting, 3rd September 2012, Royal College of Surgeons inIreland.2012

37. RNA interference treatment, using eye drops, validated using Meesmann’s cornealdystrophy.TheXIVBowmanClubAnnualMeeting,Newcastle,UK.2012

38. PterygiumSurgerywithoutglueorsuturesASCRSSanFrancisco201339. Multifocals in macular disease. BSRS Annual Congress 29th June, The Belfry, West

Midlands.201340. Identifying Potent and Specific siRNAs for Allele Specific Gene Silencing in Diseases

Following aDominantNegative Pathomechanism. BIT’sWorldGeneConvention on 14thNovember,Haikou,China.2013

41. Assessment of allele-specific gene silencing siRNAs in an ex vivo pre-clinical model oflatticetype Icornealdystrophy. IrishSocietyofHumanGenetics2013ScientificMeetingon6thSeptember,BelfastCityHospital.2013

42. DevelopmentofallelespecificgenesilencingsiRNAsforTGFBIArg124CysinLatticeCornealDystrophyTypeI.NorthernIrelandInfection&ImmunityTRGMeetingon25thFebruary,Belfast,UK.2014

43. DevelopmentofallelespecificgenesilencingsiRNAsforTGFBIArg124CysinLatticeCornealDystrophyType.VisionTRGmeetingBelfast.2014

44. Development of Allele-specific Therapeutic siRNA for Meesmann's Epithelial CornealDystrophy. 20-21March 2014. 6th Ocular Diseases & Drug Discovery Conference, SanDiego2014

45. DevelopmentofallelespecificgenesilencingsiRNAsforTGFBIArg124CysinLatticeCornealDystrophyTypeI.ARVOon7thMay,Orlando,USA.2014

46. Corneal Disease in vitro and in vivo models for development of novel therapeuticapproaches.FromCellstoTissues,TissueRepairandTissueEngineeringforDiabetes,EyeDisease and Neurodegenerative Diseases. 17th-18th September, The HELIX, Dublin CityUniversity.2014

47. Development of Novel Therapeutic Approaches to Corneal Disease. Vision TRGmeetingBelfast20thFebruary2015

48. Novelallele-specificcleavageofmutantKRT12invitroandinvivobyCRISPR/Cas9throughtheutilisationofaSNP-derivedPAM.EMBOBirmingham,UK.September2015

PosterPresentations

1. The Use of Apraclonidine to Prevent Post-Operative Intraocular Pressure Rise,OphthalmologyAlumniMeeting,RoyalVictoriaHospital,Belfast.1994

2. Behcets Disease in Northern Ireland, Ophthalmology Alumni Meeting, Royal VictoriaHospital,Belfast.1995

3. Endophthalmitis Following Cataract Surgery, Irish College of Ophthalmology Meeting,Ireland.1995

4. AdvancedGlycationandProductFormationontheVitreousCollagenNetworkisIncreasedDuring Diabetes and Hyperglycaemia, British Diabetic AssociationMedical and ScientificSectionSpringMeeting,Harrogate.1997

5. OcularSurfacereconstructioninLOGICsyndromebyAmnioticMembraneTransplantation,AssociationforResearchinVision&Ophthalmology,ARVO,Florida,USA.2001

6. TheInflammatoryMilieuAssociatedwithConjunctivalisedCorneaand itsalterationusingIL-1RAgenetherapy,AssociationforResearchinVision&Ophthalmology,ARVO,Florida,USA.2002

7. AModulatoryRoleforAGEsinRetinalMicrovascularLeukostasis.AssociationforResearchinVision&Ophthalmology,ARVO,Florida,USA.2002

8. Corneal Gene Therapy with IL-1 RA Inhibits Corneal Neovascularisation and SuppressesRejectioninPenetratingKeratoplasty.AssociationforResearchinVision&Ophthalmology,ARVO,Florida,USA.2002

9. TheRoleofAdvancedGlycationEnd-Products(AGEs) inRetinalMicrovascularLeukostasisPresented at the Association for Research in Vision & Ophthalmology, (ARVO) FortLauderdale,FloridaUSA.2002

10. Endoscopic visualisation to aid deep anterior lamellar keratoplasty, The Royal College ofOphthalmologistsannualcongress,BirminghamUK.2003

11. Endothelial Cell Density and Contrast Sensitivity in Patientsafter Deep LamellarKeratoplasty. Association for Research in Vision & Ophthalmology, ARVO, Florida, USA.2004

12. TheeffectofphacoemulsificationuponendothelialcellcountsESCRS.200413. Comparisonofroutinebacteriologyculturetomoleculardetectionmethodsforanalysisof

ocular bacterial flora. The 4th international conference on the lacrimal gland, tear film,ocularsurfaceanddryeyesyndrome:BasicScienceandclinicalrelevance,Fajardo,PuertoRico,USA.2004

14. HerpesSimplexKeratitisResearchProjectRecognisedResearchGroupInfectiousDiseasesNI.2004

15. Theeffectofatmosphericplasmasurfacetreatmentofpoly(methylmethacrylate)PMMAon corneal epithelial cell growth, protein absorption and cytokine expression’. EuropeanAssociationforVision&EyeResearch,Vilamoura,Portugal.2004

16. The Analysis of Bacterial Flora In Dry Eye. International Tear Film and Ocular SurfaceConferenceinPuertoRico.2004

17. Theeffectofatmosphericplasmasurfacetreatmentofpoly(methylmethacrylate)PMMAon corneal epithelial cell growth and protein absorption. UK Society for Biomaterials,UniversityofBrighton,UK.2004

18. Toevaluatetheeffectofon-axisarcuatekeratotomiesinphacoemulsificationonreducingpreoperative corneal astigmatismand topredict theastigmaticoutcomeof the incisionsASCRS.2005

19. To evaluate the effect on corneal astigmatism of using an injected IOL compared to afoldedIOL.TodeterminewhethereitherIOLtypeorhapticpositionresultedinvariationinlevelsofintraocularastigmatismASCRS.2005

20. Toevaluatetheeffectofon-axiscornealincisionsinphacoemulsificationonpostoperativecorneal and manifest astigmatism and to determine whether on-axis surgery is a morereproduciblewaytoimprovepostoperativeastigmaticcataractresults.Tocharacterizeanyvariationinsurgicallyinducedrefractivechangedependentontheaxisofcornealincisionandwhetherthishadanycorrelationwithintraocularastigmatism.ASCRS.2005

21. Efficacyof an in-vivo antibodybased assay for thedetectionof herpes simplex keratitis.Ophthalmology7thAlumniMeetingBelfastRoyalVictoriaHospital,BelfastNI.2005

22. TheAnalysisofBacterialFlora InDryEyeSocietyofGeneralMicrobiologymeetingUlsterUniversity,Coleraine.2005

23. Expression of P63 in Normal and Diseased Ocular Surface Tissue. Ophthalmology 7thAlumniMeeting,BelfastNI.2005

24. Staphylococcus epidermidis: Friend or Foe in Dry Eye, it’s Interaction with ConjunctivalGoblet Cells. British Society for Immunology-Pathogen Interaction with the ImmuneSystemMeeting,StranmillisUniversityCollege,Belfast.2006

25. Ocular SurfaceBacterial Flora -AConundrum. British Society for Immunology-PathogenInteractionwiththeImmuneSystemMeeting,StranmillisUniversityCollege,Belfast.2006

26. Staphylococcus epidermidis: Friend or Foe in Dry Eye, its Interaction with ConjunctivalGoblet Cells. European Association for Vision and Eye Research (EVER) InternationalConference,Portugal.2006

27. Ocular Surface Bacterial Flora - A Conundrum. EuropeanAssociation for Vision and EyeResearch(EVER)InternationalConference,Portugal.2006

28. Whichismoredifficult:theTesttoUseortheDiagnosisofDryEye.EuropeanAssociationforVisionandEyeResearch(EVER)InternationalConference,Portugal.2006

29. Ocular SurfaceBacterial Flora -AConundrum. InfectiousDiseasesRRGAnnualMeeting,Ballycastle,N.Ireland.2006

30. Proteomic analysis of conjunctival swab by mass spectrometry. TFOS, Sicilyhttp://www.tearfilm.org/content/taormina/taobook.pdf.2007

31. Proteomic analysis of conjunctival swab by mass spectrometry. EVER, Sloveniawww.ever.be2007

32. Proteomic analysis of conjunctival swab bymass spectrometry. Infectious Diseases RRGAnnualMeeting,Ballycastle,N.Ireland.2007

33. Difficulties imaging herpes simplex keratitis with fluorescein isothiocynate-labeled anti-HSV-1antibodiesinanexvivomodel.InfectiousDiseasesRRGAnnualMeeting,Ballycastle,N.Ireland.2007

34. Proteomicanalysisofconjunctivalswabbymassspectrometry.VisionScienceRRGAnnualMeeting,Ballymena,N.Ireland.2007

35. Difficulties imaging herpes simplex keratitis with fluorescein isothiocynate-labeled anti-HSV-1antibodies inanexvivomodel.VisionScienceRRGAnnualMeeting,Ballymena,N.Ireland.2007

36. Pathogenorcommensal:apcrbasedstudyofocularsurfacebacterialflorainnormalanddryeyes.InternationalTearFilmandOcularSurfaceConferenceinSicily.2007

37. Correlation between diagnostic tests guides the development and use of a dry eyediagnosticalgorithm.InternationalTearFilmandOcularSurfaceConferenceinSicily.2007

38. ProteomicanalysisofconjunctivalswabbymassspectrometryInternationalTearFilmandOcularSurfaceConferenceinSicily.2007

39. Mutation-specificsiRNAtherapyforepidermolysisbullosasimplex.SocietyofInvestigativeDermatology,Atlanta,USAhttp://sid.abstractcentral.com/viewer2010

40. Development of allele-specific therapeutic siRNA in Meesmann epithelial cornealdystrophy.IrishCollegeofOphthalmologistsAnnualConference,Cavan,2011

41. Effect of tear hyperosmolarity and signs of clinical ocular surface pathology uponconjunctival goblet cell function in the human ocular surface. Irish College ofOphthalmologistsAnnualConference,Cavan,2010

42. Development of allele-specific therapeutic siRNA in Meesmann epithelial cornealdystrophy.ARVOFortLauderdale.2011

43. AComparisonofDryEyeDiagnostic TestsWithinAnOptometricPopulation. ARVOFortLauderdale.2011

44. A comparison of the clinical and molecular diagnosis of herpes simplex. ARVO FortLauderdale.2011

45. EffectofIncreasingTearOsmolarityandDryEyeSeverityonGobletCellPopulationintheHumanOcularSurface.ARVOFortLauderdale.2011

46. SuturelessandGluelessPterygiumsurgery. XXXIAnnualConferenceof theMaharashtraOphthalmological Society & 4th Annual Conference of Poona Ophthalmological Society,India.2011

47. Multifocal lens implants and Amblyopia. XXXI Annual Conference of the MaharashtraOphthalmological Society & 4th Annual Conference of Poona Ophthalmological Society.2011

48. Alumni Belfast ‘A novel approach to treatment of non-healing corneal epithelial defectswithautologouswholeblood’MooreJE,SharmaA,ArmstrongD.2012

49. MultifocalIOLusageinamblyopesASCRSSanFrancisco.201350. SuturelessandGlue-freeConjunctivalAutograft inPterygiumSurgery:AFollow-upStudy

EucorneaESCRSAmsterdam.201351. A novel approach to treatment of non-healing corneal epithelial defects with self-

administration of finger prick autologous whole blood (FAB method) Eucornea ESCRSAmsterdam.2013

52. siRNA mediated allele specific knockdown of mutant Keratin 12 in a preclinical ex vivoMECDmodel.IrishSocietyofHumanGenetics2013ScientificMeetingon6thSeptember,BelfastCityHospital.2013

53. Development of Allele-specific Therapeutic siRNA Keratin 12 Leu132Pro in Meesmann’sEpithelialCornealDystrophy.VisionTRG,Belfast,14thMarch.2014

54. Protection of corneal epithelial stem cells prevents ultraviolet A damage during cornealcollagencross-linkingtreatmentforkeratonconus.VisionTRG,Belfast,14thMarch.2014

55. TheUseoftheLENTISMplusmultifocalIOLinpatientswithmacularproblems.VisionTRG,Belfast,14thMarch.2014

56. The Use of the LENTIS Mplus multifocal IOL in patients with macular problems. ESCRSLondon13thSept.2014

57. Identifying the role of matrix metalloproteinases in the pathomechanism of TGFBIArg124CysrelatedLatticeCornealDystrophyTypeI.Arvoon4thMay,OrlandoUSA.2014

58. Composition of corneal stromal aggregates associated with Lattice and Granular type 1variantsofTGFBIrelatedcornealdystrophies.VisionTRG,Belfast.20thFebruary2015

59. Allele specific therapeutic siRNAs for three Keratin 3 Meesmann’s Corneal Dystrophydiseasecausingmutations.VisionTRG,Belfast.20thFebruary2015

60. WholeexomesequenceanalysisidenitifiesnovelKeratoconusgenesintwoNorthernIrishfamilies.VisionTRG,Belfast.20thFebruary2015

61. In vivo gene silencing by siRNA delivery to the corneal epithelium in a keratin-12-bioluminescencemousemodel.3rdMay2015,Denver,Colorado2015

62. AmutatedallelewithCRISPR/case.9forautosomaldominantgeneticeyediseases.108thannualcongressofSwissSocietyofOphthalmology.Fribourg26thto28thAugust2015

63. Developingmutantallele-specificCRISPR/Cas9geneeditingfordominant-negativegeneticeye disease. 108th Congress of the Swiss Society of Ophthalmology, Fribourg. 26-28thAugust.2015

64. A case of a corneal melting with perforation managed with CXL and delayed cornealtransplantation.108thCongressoftheSwissSocietyofOphthalmology,Fribourg.26-28thAugust.2015

65. In vivo gene silencing by siRNA delivery to the corneal epithelium in a keratin-12-bioluminescencemousemodel.ISHG,DublinCityUniversity4thSeptember2015

66. UnfoldedProteinResponseinamousemodelofMessmann’sEpithelialCornealDystrophy.ISHG,DublinCityUniversity4thSeptember2015

67. WholeexomesequenceanalysisinamultigenerationNorthernIrishfamilywithPterygium.ISHG,DublinCityUniversity4thSeptember2015

68. Mutant allele-specific gene silencing in autosomal dominantly inherited Fuchs’ cornealdystrophyusingCRISPRCas9nuclease.ISHG,DublinCityUniversity4thSeptember2015

69. Cyclosporine A 0.05% emulsion after cataract surgery for ocular surface problems andcornealsensation.6thEuCorneaCongressinBarcelona.5th-9thSeptember2015

70. Physiological variations in pupil size and eccentricity of visual axis (angle kappa) impactqualityofvisioninasymmetricmultifocalintraocularlensimplants.6thEuCorneaCongressinBarcelona.5th-9thSeptember2015.

71. ‘Eyepeace’isaneffectivenew‘massagingtool’fortreatmentofevaporativedryeyeduetoobstructive meibomian gland disease. 6th EuCornea Congress in Barcelona. 5th-9thSeptember2015

72. Functionalandneuroadaptiveeffectsincataractandclearlensextractioncharacterisedviaaqualityofvisionquestionnaire.6thEuCorneaCongressinBarcelona5th-9thSeptember

73. Novelallele-specificcleavageofmutantKRT12invitroandinvivobyCRISPR/Cas9throughtheutilisationofaSNP-derivedPAM.EMBOBirmingham,UK.September2015

74. Thedevelopment of allele-specific CRISPR/Cas9 based therapeutics for corneal disordersThe Cold Spring Harbour Labs on 'Genome Engineering: The CRISPR/Cas Revolution.September24-27,2015NewYork,USA.

75. GeneticmodificationpossibilitiesintreatingcornealdiseasesEVER,Nice,France:October7-10,2015

76. Visualoutcomesandpatientsatisfactionthreeandtwelvemonthsafterimplantationofanewrefractiverotationallyasymmetricmultifocalintraocularlens.ESCRSAnnualCongress,Copenhagen,2016

77. Optimalpupilsizeanditsimplicationspostrotationallyasymmetricalmultifocalintraocularlens(MFIOL)implantation.ESCRSAnnualCongress,Copenhagen,2016

78. Toassessvisualresultsafterbilateral implantationofasymmetricalmultifocal intraocularlens(MFIOL)focusedfordistanceandnear.ESCRSAnnualCongress,Copenhagen,2016